This likely occurs through DDX5‐mediated transcription, which was demonstrated using the survivin gene as an example (Figure 4); and (3) DDX5 appears to be a biomarker for reflecting PDAC and CRC tumour sensitivity to FL118 treatment (Figures 5 and 6). This evidence concerns the gene BIRC5 and colorectal carcinoma.